Please login to the form below

Not currently logged in
Email:
Password:

rolapitant

This page shows the latest rolapitant news and features for those working in and with pharma, biotech and healthcare.

Tesaro joins PARP parade with US approval of Zejula

Tesaro joins PARP parade with US approval of Zejula

The approval comes at a buoyant time for Tesaro, which is still rolling out its first commercial product in the US - the chemotherapy-induced nausea and vomiting drug Varubi (rolapitant) - and

Latest news

More from news
Approximately 1 fully matching, plus 3 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Videum Health

Videum Health is a premium video platform that offers brands innovative engagement strategies to reach targeted healthcare audiences on a...

Latest intelligence

ACCOMPLISH MEANINGFUL HCP ENGAGEMENT ONLINE
The art of delivering valuable customer journeys aligned to your key messages in 2020...
DEMAND DIVERSITY REPORT 01: Exploring attitudes towards clinical research among people from different ethnic groups in the UK
This report reveals insights from the people themselves, and discusses the starting points for overcoming current challenges....
Why are new medicinal products denied reimbursement in France?
Many medicinal products looking to launch are rejected for reimbursement in France. A manufacturer must convince the Transparency Committee that their product is safe, effective and offers added value relative...

Infographics